Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Apr 26, 2011 (rev. 1)

Premium

Caren Mason has been named CEO and has joined the board of directors of Verinata Health, which recently changed its name from Artemis Health.

Mason has more than 30 years of commercial and diagnostic healthcare experience. Previously, she served as president and CEO of Quidel, a point-of-care, rapid immunoassay diagnostics test company. She also served as CEO of MiraMedica, a company that designs computer-aided detection software to assist radiologists in breast screening, and as CEO of eMed Technologies, a company focused on digital technology for transferring information and images between hospitals and doctors. In addition, she has served as a general manager of the women's healthcare and services business of GE Healthcare and as a senior vice president for Bayer.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.